US1897631057
© PR Newswire
09.12.2025
CODX
LISTED
NASDAQ
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
News Preview
SALT LAKE CITY, Dec. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Company is delivering a presentation at the Point-of-Care Testing 2025 Exhibition and Conference in...
Themefolio
Profiler
Peergroup
© PR Newswire
08.12.2025
CODX
LISTED
NASDAQ
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
News Preview
Ongoing Phase II preclinical study data for Co-Dx PCR MTB and HPV tests support advancement to clinical performance testing
SALT LAKE CITY, Dec. 8, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the developm...
Themefolio
Profiler
Peergroup
© PR Newswire
20.11.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
News Preview
SALT LAKE CITY, Nov. 20, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Company's Executive Vice President of Business Development, Jos...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
18.11.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA
News Preview
SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has begun clinical evaluations for its Co-Dx™ PCR Flu A/B, COVID...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
13.11.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Reports Third Quarter 2025 Financial Results
News Preview
SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its financial results for the third quarter ended Sep...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2025
CODX
LISTED
NASDAQ
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
News Preview
SALT LAKE CITY, Nov. 12, 2025 /PRNewswire/ -- Governor Spencer Cox joins Kelvyn Cullimore of BioUtah in recognizing Co-Diagnostics, Inc. (Nasdaq: CODX), a Utah diagnostics company with a patented platform for developing advanced molecular diagnostic tests, following its recent announcement of the formation of CoM...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
News Preview
SALT LAKE CITY, Nov. 5, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular diagnostic tests, today announced that it has engaged Maxim Group LLC ("Maxim") as its exclusive financial advisor...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
CODX
LISTED
NASDAQ
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
News Preview
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx's existing and future AI initiatives
SALT LAKE CITY, Nov. 3, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
News Preview
SALT LAKE CITY, Oct. 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2025 financial results on Thursday, November 13, 2025, after the...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
News Preview
SALT LAKE CITY, Oct. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host a virtual fireside chat on Wednesday, November 5, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced offering of 12,727,272 shares of...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Oct. 28, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase agreement with several in...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
27.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East
News Preview
The new Saudi-based CoMira Diagnostics joint venture will be engaged in manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP across KSA and 18 other MENA countries
SALT LAKE CITY,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia
News Preview
Conference attendance follows recent MOU announcement for a joint venture with a regional manufacturing and distribution company in the Kingdom of Saudi Arabia
SALT LAKE CITY, Oct. 22, 2025 /PRNewswire/ -- Co-Diagnostics,...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing
News Preview
New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing efforts to improve availability of life-saving TB diagnostics
SALT LAKE CITY, Oct. 16, 2025 /PRNewswire/ -- Co-Diagnostics, In...
Themefolio
Profiler
Peergroup
© PR Newswire
13.10.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
News Preview
SALT LAKE CITY, Oct. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today its participation in the upcoming 2025 Maxim Growth Summit, taking place...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
News Preview
SALT LAKE CITY, Sept. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in a webcast presentation and hosting one...
Themefolio
Profiler
Peergroup
© PR Newswire
18.09.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Sept. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced registered direct offering pursuant to a securities purchase agre...
Themefolio
Profiler
Peergroup
© PR Newswire
17.09.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Sept. 17, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase agreement with several institutional investors for the pur...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
News Preview
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP
SALT LAKE CITY, Sept. 16, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
News Preview
SALT LAKE CITY, Sept. 11, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has performed an in silico analysis of the primers sets used in its Co-Primers®-based PCR tests f...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit
News Preview
SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that Co-Dx™ was an honoree at the Utah Business 2025 Innovation Awards Summit for the Co-Dx PCR platform*,...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
News Preview
SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended June 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
15.07.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025
News Preview
SALT LAKE CITY, July 15, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at WHX (World Health Expo) Kuala Lumpur on July 16-18, 2025, at the Mal...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.05.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
News Preview
Salt Lake City, Utah, May 14, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that they will be participating in the D. Boral Capital (“DBC”) Inaugural Global Conference on Ma...
Themefolio
Profiler
Peergroup
© PR Newswire
27.03.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
News Preview
SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the fourth quarter and full year ended December 31, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
13.03.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast
News Preview
SALT LAKE CITY, March 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its fourth quarter and full year 2024 results on Thursday, March 27, 2025, after the market close. The Company will...
Themefolio
Profiler
Peergroup
© PR Newswire
06.03.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit
News Preview
SALT LAKE CITY, March 6, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on March 4, 2025, the Securities & Governance Litigation Team at BakerHostetler, the legal firm r...
Themefolio
Profiler
Peergroup
© PR Newswire
03.03.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
News Preview
The symposium exploring advances in cancer prevention and care is set to take place on March 4, International HPV Awareness Day, in Baroda, India
SALT LAKE CITY, March 3, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of mole...
Themefolio
Profiler
Peergroup
© PR Newswire
21.02.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
News Preview
The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,...
Themefolio
Profiler
Peergroup
© PR Newswire
30.01.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill
News Preview
SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it will be hosting a booth at BioUtah's Life Sciences Day on the Hill today at the Utah State Capitol Ro...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2025
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025
News Preview
SALT LAKE CITY, Jan. 7, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in Nasdaq's Live from MarketSite broadcast at the Silicon Slopes Summit 20...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
News Preview
New oligonucleotide facility is designed to support "Make in India" initiative by synthesizing Co-Primers® in-house. Attendees of new ribbon-cutting event expected to include representatives from NGOs and government leaders
SALT LAKE CITY, Dec. 10, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular di...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
News Preview
New oligonucleotide facility is designed to support "Make in India" initiative by synthesizing Co-Primers® in-house. Attendees of new ribbon-cutting event expected to include representatives from NGOs and government leaders
SALT LAKE CITY, Dec. 10, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular di...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
News Preview
SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended September 30, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
News Preview
SALT LAKE CITY, Nov. 5, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldor...
Themefolio
Profiler
Peergroup
© PR Newswire
25.10.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast
News Preview
SALT LAKE CITY, Oct. 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2024 results on Thursday, November 7, 2024, after the market close. The Company will also host a co...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024
News Preview
SALT LAKE CITY, Oct. 21, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be hosting a booth at Africa Health/Medlab Africa in Cape To...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3
News Preview
SALT LAKE CITY, Oct. 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be hosting a booth at the Utah Health Care Association/Utah Center for Assisted...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan
News Preview
SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor's Office of Economic Opportunity,...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
News Preview
SALT LAKE CITY, Sept. 5, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has performed an in silico analysis of the Co-Dx™ Logix Smart® Mpox (2-Gene) RUO test to evaluate...
Themefolio
Profiler
Peergroup
© PR Newswire
15.08.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.
News Preview
SALT LAKE CITY, Aug. 15, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be sponsoring, presenting and hosting a booth at the 16th Annual Next Generation Dx Summit, held virt...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results
News Preview
SALT LAKE CITY, August 8, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended June 30, 2024....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
